AIM VACCINE News

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 05:08 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

May 7 05:01 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

May 7 04:53 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

May 7 04:46 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

May 7 04:38 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

May 7 04:31 ET

AIM VACCINE: FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2024

Apr 25 05:42 ET

AIM VACCINE: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 25 05:21 ET

AIM VACCINE: Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors

Apr 19 07:12 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER

Apr 18 07:44 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 05:02 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Apr 3 04:56 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Apr 3 04:48 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Apr 3 04:38 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Apr 3 04:31 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE SUBMIT

Mar 27 20:03 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR QUADRIVALENT INFLUENZA VIRUS VACCINE (MDCK CELLS) SUBMITTED

Mar 27 20:00 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR NOVEL-PROCESS HIGHLY-EFFECTIVE HUMAN DIPLOID RABIES VACCINE SUBMITTED

Mar 26 09:20 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR ABSORBED TETANUS VACCINE SUBMITTED

Mar 3 19:00 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II CLINICAL TRIAL OF TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE

Mar 3 18:54 ET